Mettler-Toledo International (NYSE:MTD) Cut to Hold at Wall Street Zen

Wall Street Zen cut shares of Mettler-Toledo International (NYSE:MTD) from a buy rating to a hold rating in a report released on Saturday morning.

Several other research firms have also weighed in on MTD. The Goldman Sachs Group initiated coverage on Mettler-Toledo International in a research report on Tuesday, December 9th. They set a “neutral” rating and a $1,475.00 price target on the stock. Morgan Stanley initiated coverage on shares of Mettler-Toledo International in a report on Tuesday, December 2nd. They set an “equal weight” rating and a $1,550.00 target price on the stock. Wells Fargo & Company upped their target price on shares of Mettler-Toledo International from $1,400.00 to $1,450.00 and gave the stock an “equal weight” rating in a research report on Monday, December 15th. Barclays lowered their price target on shares of Mettler-Toledo International from $1,600.00 to $1,550.00 and set an “overweight” rating for the company in a research report on Monday, December 15th. Finally, Evercore ISI upped their price objective on shares of Mettler-Toledo International from $1,275.00 to $1,400.00 and gave the stock an “outperform” rating in a report on Tuesday, October 7th. Six equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and an average target price of $1,441.67.

Mettler-Toledo International Trading Up 1.0%

Shares of MTD opened at $1,386.95 on Friday. The firm’s 50-day moving average price is $1,430.65 and its 200-day moving average price is $1,355.66. The firm has a market capitalization of $28.34 billion, a price-to-earnings ratio of 34.59, a PEG ratio of 4.08 and a beta of 1.42. Mettler-Toledo International has a 1-year low of $946.69 and a 1-year high of $1,525.17.

Mettler-Toledo International (NYSE:MTD) last released its quarterly earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $10.62 by $0.53. The company had revenue of $1.03 billion during the quarter, compared to the consensus estimate of $997.36 million. Mettler-Toledo International had a net margin of 21.20% and a negative return on equity of 426.96%. Mettler-Toledo International’s revenue was up 7.9% on a year-over-year basis. During the same period in the prior year, the firm earned $10.21 earnings per share. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS and its FY 2025 guidance at 42.050-42.250 EPS. On average, research analysts forecast that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insiders Place Their Bets

In other Mettler-Toledo International news, insider La Guerroniere Marc De sold 6,880 shares of the stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $1,450.00, for a total transaction of $9,976,000.00. Following the sale, the insider directly owned 187 shares in the company, valued at approximately $271,150. This trade represents a 97.35% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Patrick Kaltenbach sold 2,000 shares of the business’s stock in a transaction on Wednesday, November 12th. The stock was sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the completion of the transaction, the chief executive officer owned 3,670 shares of the company’s stock, valued at $5,367,375. This represents a 35.27% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 19,565 shares of company stock worth $28,683,737 in the last three months. Corporate insiders own 0.77% of the company’s stock.

Institutional Trading of Mettler-Toledo International

A number of institutional investors have recently made changes to their positions in the stock. Geneos Wealth Management Inc. boosted its holdings in Mettler-Toledo International by 83.3% in the first quarter. Geneos Wealth Management Inc. now owns 66 shares of the medical instruments supplier’s stock worth $78,000 after purchasing an additional 30 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its stake in shares of Mettler-Toledo International by 7.7% in the 2nd quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,680 shares of the medical instruments supplier’s stock worth $3,148,000 after buying an additional 192 shares during the last quarter. Impact Investors Inc grew its holdings in shares of Mettler-Toledo International by 11.0% in the second quarter. Impact Investors Inc now owns 313 shares of the medical instruments supplier’s stock worth $368,000 after acquiring an additional 31 shares during the period. Valeo Financial Advisors LLC purchased a new stake in Mettler-Toledo International during the second quarter valued at $234,000. Finally, Slow Capital Inc. lifted its holdings in Mettler-Toledo International by 5.4% in the second quarter. Slow Capital Inc. now owns 4,469 shares of the medical instruments supplier’s stock valued at $5,249,000 after acquiring an additional 229 shares during the period. Hedge funds and other institutional investors own 95.07% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.